Protagonist Therapeutics, Inc. (PTGX)
92.09
+0.68
(+0.74%)
USD |
NASDAQ |
Mar 06, 16:00
93.01
+0.92
(+1.00%)
After-Hours: 20:00
Protagonist Therapeutics Free Cash Flow : 56.08M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Johnson & Johnson | 19.70B |
| ADMA Biologics, Inc. | 27.50M |
| Glaukos Corp. | -39.06M |
| Krystal Biotech, Inc. | 188.91M |
| Olema Pharmaceuticals, Inc. | -134.67M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -36.98M |
| Cash from Investing (Quarterly) | 48.82M |
| Cash from Financing (Quarterly) | 2.837M |
| Free Cash Flow Per Share (Quarterly) | -0.5797 |
| Free Cash Flow to Equity (Quarterly) | -36.69M |
| Free Cash Flow to Firm (Quarterly) | -37.12M |
| Free Cash Flow Yield | 0.96% |